| Medicinal potential of Passiflora foetida L. plant extracts: biological and pharmacological activities M Asadujjaman, AU Mishuk, MA Hossain, UK Karmakar Journal of integrative medicine 12 (2), 121-126, 2014 | 59 | 2014 |
| National trends in prescription proton pump inhibitor use and expenditure in the United States in 2002-2017 QJ Mishuk AU, Chen L, Gaillard P, Westrick S, Hansen RA Journal of the American Pharmacists Association 61 (1), 87-94. e7, 2021 | 35 | 2021 |
| Novel approaches in lipid based drug delivery systems A Md, MA Ullah Journal of Drug Delivery & Therapeutics 3 (4), 124-130, 2013 | 33 | 2013 |
| Impact of US federal and state generic drug policies on drug use, spending, and patient outcomes-A systematic review AU Mishuk, I Fasani, J Qian Research in Social and Administrative Pharmacy, 2019 | 26 | 2019 |
| The association between patient sociodemographic characteristics and generic drug use: a systematic review and meta-analysis AU Mishuk, J Qian, JN Howard, I Harris, G Frank, Z Kiptanui, R Hansen Journal of managed care & specialty pharmacy 24 (3), 252-264, 2018 | 24 | 2018 |
| Assessing clinician utilization of next-generation antibiotics against resistant Gram-negative infections in US hospitals: a retrospective cohort study JR Strich, A Mishuk, G Diao, A Lawandi, W Li, CY Demirkale, A Babiker, ... Annals of internal medicine 177 (5), 559-572, 2024 | 11 | 2024 |
| Safety of dietary supplements use among patients with cancer: A systematic review Z Zeng, AU Mishuk, J Qian Critical reviews in oncology/hematology 152, 103013, 2020 | 10 | 2020 |
| Adverse event reporting patterns of concomitant botanical dietary supplements with CYP3A4 interactive & CYP3A4 non-interactive anticancer drugs in the US Food and Drug … SM Fahim, AU Mishuk, N Cheng, R Hansen, AI Calderón, J Qian Expert Opinion on Drug Safety 18 (2), 145-152, 2019 | 10 | 2019 |
| A survey on traditional medicinal plants used for the treatment of diabetes in urban areas of Dhaka and Khulna, Bangladesh MM Rahman, A Mishuk, S Halder, ASS Rouf Glob. J. Med. Res. Pharma Drug Disc. Toxicol. Med 13, 21-26, 2013 | 9 | 2013 |
| Does public perception bias lead to more frequent reporting of adverse events: branded vs generic drugs J Qian, AU Mishuk, RA Hansen Expert Opinion on Drug Safety 17 (8), 753-756, 2018 | 8 | 2018 |
| Comparative analysis of adverse drug reactions in directly observed treatment short course (DOTS) in TB patients MM Rahman, A Mishuk, S Halder, AKL Kabir Glob J Med Res 13, 6-10, 2013 | 4 | 2013 |
| Assessment of phytochemical & pharmacological activities of the ethanol extracts of Xanthium indicum AU Mishuk, MA Rahman, S Afrin, MI Ahmed, SK Sadhu, F Hossain International Journal of Pharmaceutical Sciences and Research 3 (12), 4811, 2012 | 4 | 2012 |
| Generic levothyroxine initiation and substitution among Medicare and Medicaid populations: a new user cohort study N Huo, L Chen, A Ullah Mishuk, C Li, RA Hansen, I Harris, Z Kiptanui, ... Endocrine 68, 336-348, 2020 | 3 | 2020 |
| 1649. Ceftolozane-tazobactam or ceftazidime-avibactam versus best available therapy in the treatment of difficult-to-treat Pseudomonas aeruginosa infections: a retrospective … A Lawandi, AU Mishuk, C Yek, A Yu, X Li, JR Strich, S Sarzynski, ... Open Forum Infectious Diseases 9 (Supplement_2), ofac492. 115, 2022 | 2 | 2022 |
| Generic escitalopram initiation and substitution among Medicare beneficiaries: A new user cohort study C Li, L Chen, N Huo, AU Mishuk, RA Hansen, I Harris, Z Kiptanui, Z Wang, ... Plos one 15 (4), e0232226, 2020 | 2 | 2020 |
| 652. Ceftazidime-avibactam alone or as combination therapy? Multicenter retrospective cohort analysis of clinical outcomes in patients with carbapenem-resistant Gram-negative … AU Mishuk, JR Strich, S Warner, J Sun, S Malik, A Lawandi, M Kondo, ... Open Forum Infectious Diseases 9 (Suppl 2), ofac492. 704, 2022 | 1 | 2022 |
| Patient factors associated with oral generic olanzapine initiation and substitution among Medicaid beneficiaries: a new user cohort study AU Mishuk, L Chen, C Li, N Huo, RA Hansen, I Harris, Z Kiptanui, J Qian Current Medical Research and Opinion 37 (4), 655-664, 2021 | 1 | 2021 |
| Comprehensive Safety Evaluation of Proton Pump Inhibitors AU Mishuk Auburn University, 2021 | 1 | 2021 |
| Signals in types of adverse event reporting of concurrent use of botanical dietary supplements and anticancer prescriptions in the US Food and Drug Administration adverse event … J Qian, SM Fahim, AU Mishuk, A Calderon, R Hansen PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 249-249, 2018 | 1 | 2018 |
| Generic substitution patterns of levothyroxine and escitalopram in subgroups of US Medicare beneficiaries J Qian, C Li, N Huo, AU Mishuk, L Chen, R Hansen, I Harris, Z Kiptanui PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 27, 438-438, 2018 | 1 | 2018 |
Jingjing QianAuburn UniversityПідтверджена електронна адреса в auburn.edu
